Tanvex BioPharma, Inc. (TPE:6541)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
56.70
+0.10 (0.18%)
Jul 11, 2025, 1:30 PM CST

Tanvex BioPharma Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
-1,429-1,382-2,137-1,641-1,543-2,104
Upgrade
Depreciation & Amortization
311.35287.56323.59280.01241.43215.83
Upgrade
Other Amortization
2.311.481.241.552.154.58
Upgrade
Loss (Gain) From Sale of Assets
6.39-0.082.877.210.940.27
Upgrade
Asset Writedown & Restructuring Costs
49.19-8.67---
Upgrade
Stock-Based Compensation
8.01-2.16326.6167.5552.9580.36
Upgrade
Other Operating Activities
1517.88-1.23--90.20.63
Upgrade
Change in Accounts Receivable
201.079.33-9.062.19-2.52-0.72
Upgrade
Change in Inventory
-112.87-109.5562.56-80.51-40.252.12
Upgrade
Change in Accounts Payable
4.551.7533.41-15.59-66.9732.43
Upgrade
Change in Unearned Revenue
-211.72-0.56-10.9328.07--
Upgrade
Change in Other Net Operating Assets
-1.3225.3-35.9816.8258.67-18.88
Upgrade
Operating Cash Flow
-1,145-1,151-1,435-1,334-1,387-1,788
Upgrade
Capital Expenditures
-80.44-105.91-71.02-93.5-29.82-66.03
Upgrade
Sale of Property, Plant & Equipment
1.810.146.331.826.70.17
Upgrade
Sale (Purchase) of Intangibles
-3.06-4.86-0.32-2.58-0.52-1.47
Upgrade
Investment in Securities
4.7-----193.87
Upgrade
Other Investing Activities
1,0041.38-18.57-3.09-1.0417.9
Upgrade
Investing Cash Flow
927-109.25-83.57-97.35-24.68-243.3
Upgrade
Short-Term Debt Issued
-377.65----
Upgrade
Long-Term Debt Issued
-----94.87
Upgrade
Total Debt Issued
2.65377.65---94.87
Upgrade
Short-Term Debt Repaid
--377.65----
Upgrade
Long-Term Debt Repaid
--184.58-127.67-130.53-93.11-67.76
Upgrade
Total Debt Repaid
-546.27-562.23-127.67-130.53-93.11-67.76
Upgrade
Net Debt Issued (Repaid)
-543.62-184.58-127.67-130.53-93.1127.11
Upgrade
Issuance of Common Stock
1,4501,4401,2077.241,6901,703
Upgrade
Other Financing Activities
-1.5-----
Upgrade
Financing Cash Flow
904.861,2551,080-123.291,5971,730
Upgrade
Foreign Exchange Rate Adjustments
5.050.9833.91117.75-31.25-58.41
Upgrade
Net Cash Flow
691.95-3.79-405.48-1,437154.37-358.84
Upgrade
Free Cash Flow
-1,225-1,257-1,506-1,427-1,417-1,854
Upgrade
Free Cash Flow Margin
-1509.42%-3623.36%-2452.94%-6370.97%-26208.75%-617884.67%
Upgrade
Free Cash Flow Per Share
-6.91-8.09-11.69-12.14-13.05-20.71
Upgrade
Cash Interest Paid
51.653.3457.3854.7245.8117.96
Upgrade
Cash Income Tax Paid
1.451.020.880.020.020.02
Upgrade
Levered Free Cash Flow
-762.96-792.54-713.06-844.23-819.13-1,075
Upgrade
Unlevered Free Cash Flow
-730.71-759.2-677.19-810.03-790.24-1,063
Upgrade
Change in Net Working Capital
129.3387.36-55.6859.6156.93-15.83
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.